DEF 14A

Company

Merck & Co., Inc.

Filed

April 6, 2020

Period of Report

May 26, 2020

Accession Number

0001193125-20-099563

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →